OLVIG
RKDA icon

Oliver Lagore Vanvalin Investment Group’s Arcadia Biosciences RKDA Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4
Closed -$11 – 723
2024
Q3 		$11 Hold
4
– – ﹤0.01% 679
2024
Q2 		$13 Hold
4
– – ﹤0.01% 723
2024
Q1 		$9 Hold
4
– – ﹤0.01% 730
2023
Q4 		$13 Hold
4
– – ﹤0.01% 757
2023
Q3 		$13 Hold
4
– – ﹤0.01% 838
2023
Q2 		$16 Hold
4
– – ﹤0.01% 768
2023
Q1 		$30 Buy
4
+1
+33% +$11 ﹤0.01% 693
2022
Q4 		$37 Hold
3
– – ﹤0.01% 651
2022
Q3 		$0 Hold
3
– – ﹤0.01% 718
2022
Q2 		$0 Hold
3
– – ﹤0.01% 687
2022
Q1 		$0 Buy
+3
New +$143 ﹤0.01% 580

Other funds holding RKDA

Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWM
Atticus Wealth Management Palm Beach Gardens, Florida $420M AUM 23.31% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's RKDA Position: Q4 2024 in Review

Oliver Lagore Vanvalin Investment Group sold out of Arcadia Biosciences (RKDA) in Q4 2024, closing a stake of 4 shares — an estimated $11 sold.

Oliver Lagore Vanvalin Investment Group first reported a position in RKDA in Q1 2022 and held it in 11 quarters. The position peaked at $37 in Q4 2022. 13 funds tracked by Wall St. Rank hold RKDA as of Q4 2024.

  • Oliver Lagore Vanvalin Investment Group reported no remaining Arcadia Biosciences position as of Q4 2024 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 4 Arcadia Biosciences shares in Q4 2024, an estimated $11.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Arcadia Biosciences in Q1 2022 and held it in 11 quarters.
  • Oliver Lagore Vanvalin Investment Group's Arcadia Biosciences position peaked at $37 in Q4 2022.
  • 13 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q4 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q4 2024, filed 1 Apr 2025.